These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 7912491)
1. Suramin inhibits the growth of human breast cancer cell lines. Studies on parental lines and corresponding sublines with acquired doxorubicin resistance with and without expression of P-glycoprotein. Lindman H; Taube A; Bergh JC Anticancer Res; 1994; 14(2A):363-6. PubMed ID: 7912491 [TBL] [Abstract][Full Text] [Related]
2. Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases. de la Torre M; Hao XY; Larsson R; Nygren P; Tsuruo T; Mannervik B; Bergh J Anticancer Res; 1993; 13(5A):1425-30. PubMed ID: 7902062 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines. Slovak ML; Hoeltge GA; Dalton WS; Trent JM Cancer Res; 1988 May; 48(10):2793-7. PubMed ID: 2896069 [TBL] [Abstract][Full Text] [Related]
4. Suramin is synergistic with vinblastine in human colonic tumor cell lines: effect of cell density and timing of drug delivery. Frommel TO Anticancer Res; 1997; 17(3C):2065-71. PubMed ID: 9216665 [TBL] [Abstract][Full Text] [Related]
5. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA. Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833 [TBL] [Abstract][Full Text] [Related]
6. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines. Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143 [TBL] [Abstract][Full Text] [Related]
7. Reversal of inherent multidrug-resistance in primary human renal cell carcinoma cell cultures by S 9788. Efferth T; Dunn TA; Berlion M; Langenbahn H; Pommerenke EW; Volm M Anticancer Res; 1993; 13(4):905-8. PubMed ID: 8102519 [TBL] [Abstract][Full Text] [Related]
8. Drug resistance in chemotherapy for breast cancer. Saeki T; Tsuruo T; Sato W; Nishikawsa K Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():84-9. PubMed ID: 16273361 [TBL] [Abstract][Full Text] [Related]
9. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells. Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673 [TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance. Ogretmen B; McCauley MD; Safa AR Biochemistry; 1998 Aug; 37(33):11679-91. PubMed ID: 9709006 [TBL] [Abstract][Full Text] [Related]
11. Altered gene expression in drug-resistant human breast cancer cells. Wosikowski K; Schuurhuis D; Kops GJ; Saceda M; Bates SE Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2405-14. PubMed ID: 9815641 [TBL] [Abstract][Full Text] [Related]
12. Stable differentiation of a human colon adenocarcinoma cell line by sodium butyrate is associated with multidrug resistance. Ho SB; Yan PS; Dahiya R; Neuschwander-Tetri BA; Basbaum C; Kim YS J Cell Physiol; 1994 Aug; 160(2):213-26. PubMed ID: 7913708 [TBL] [Abstract][Full Text] [Related]
13. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells. Wang TX; Yang XH Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331 [TBL] [Abstract][Full Text] [Related]
14. The multidrug-resistance modifiers verapamil, cyclosporine A and tamoxifen induce an intracellular acidification in colon carcinoma cell lines in vitro. Hamilton G; Cosentini EP; Teleky B; Koperna T; Zacheri J; Riegler M; Feil W; Schiessel R; Wenzi E Anticancer Res; 1993; 13(6A):2059-63. PubMed ID: 7905252 [TBL] [Abstract][Full Text] [Related]
15. Modulatory effects of tamoxifen and recombinant human alpha-interferon on doxorubicin resistance. Kang Y; Perry RR Cancer Res; 1993 Jul; 53(13):3040-5. PubMed ID: 8100483 [TBL] [Abstract][Full Text] [Related]
16. CG5/Dx human breast cancer cell line: characterization of a new doxorubicin-resistant variant. Gibelli N; Zibera C; Asti A; Maestri L; Bacchella L; Pedrazzoli P; Calligaro A; Robustelli della Cuna G Anticancer Res; 1996; 16(4A):1675-81. PubMed ID: 8712686 [TBL] [Abstract][Full Text] [Related]
17. Scanning electron microscopy of multidrug resistant cells in haematological and mammary malignancies. Galimberti S; Bianchi F; Bernardini N; Mattii L; Dolfi A; Lupetti M; Petrini M Cell Mol Biol (Noisy-le-grand); 1993 Jul; 39(5):543-51. PubMed ID: 8104068 [TBL] [Abstract][Full Text] [Related]
18. Specific targeting and killing activities of anti-P-glycoprotein monoclonal antibody MRK16 directed against intrinsically multidrug-resistant human colorectal carcinoma cell lines in the nude mouse model. Iwahashi T; Okochi E; Ariyoshi K; Watabe H; Amann E; Mori S; Tsuruo T; Ono K Cancer Res; 1993 Nov; 53(22):5475-82. PubMed ID: 8106147 [TBL] [Abstract][Full Text] [Related]
19. Actinomycin D causes multidrug resistance and differentiation in a human rhabdomyosarcoma cell line. Melguizo C; Prados J; Fernández JE; Vélez C; Alvarez L; Aránega A Cell Mol Biol (Noisy-le-grand); 1994 Mar; 40(2):137-45. PubMed ID: 7911694 [TBL] [Abstract][Full Text] [Related]
20. Detection of P-glycoprotein in solid tumors by flow cytometry. Fujii H; Tanigawa N; Muraoka R; Shimomatsuya T; Tanaka T Anticancer Res; 1993; 13(6A):2171-5. PubMed ID: 7905253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]